Author:
Sun Shui-mei,Xie Zhi-fu,Zhang Yang-ming,Zhang Xin-wen,Zhou Chen-dong,Yin Jian-peng,Yu Yan-yan,Cui Shi-chao,Jiang Hao-wen,Li Teng-teng,Li Jia,Nan Fa-jun,Li Jing-ya
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference52 articles.
1. Kolovou GD, Anagnostopoulou KK, Cokkinos DV. Pathophysiology of dyslipidaemia in the metabolic syndrome. Postgrad Med J. 2005;81:358–66.
2. Genest JG Jr. Dyslipidemia and coronary artery disease. Can J Cardiol. 2000;16(Suppl A):3A–4A.
3. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2019;73:e285–350.
4. Zhang M, Deng Q, Wang LH, Huang ZJ, Zhou MG, Li YC, et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163,641 adults. Int J Cardiol. 2018;260:196–203.
5. Kim J, Yang G, Kim Y, Kim J, Ha J. AMPK activators: mechanisms of action and physiological activities. Exp Mol Med. 2016;48:e224.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献